ProfileDr. Josh Rising is Pew’s director of health care programs, overseeing the health information technology project, the substance use prevention and treatment initiative, and the improving end-of-life care project.
Before joining Pew, Rising helped establish the Office of Policy in the Food and Drug Administration’s Center for Tobacco Products. He also served as health policy analyst for the Connecticut Legislature, focusing on issues of health care access, Medicaid policy, health information technology, and health care quality. He also was legislative affairs director for the American Medical Student Association.
Rising received his medical degree and his master’s degree in public health from Boston University, completed his pediatric residency at the University of California, San Francisco, and trained for a year as a Robert Wood Johnson clinical scholar at Yale University.
Recent WorkView All
Prescription drug monitoring programs (PDMPs) are electronic databases that allow health care professionals to view their patients’ controlled-substance prescription histories in order to better inform prescribing, dispensing, and treatment decisions. PDMPs can help reduce the misuse and diversion of prescription opioids and other controlled substances. Read More
The Pew Charitable Trusts sent a letter April 23 to the House Energy and Commerce Committee asking members to focus on legislative proposals to improve access to high-quality treatment for people with substance use disorders. Read More
The transition from paper medical records to electronic health records (EHRs) has transformed health careand improved safety and quality. Digitizing has also highlighted issues with usability—how clinicians interactwith EHR systems—that can contribute to patient harm. Varied EHR formats and a lack of consistent, intuitiveinterfaces—combined with EHR customization by health care... Read More